Skip to content

Tablo® for Nephrologists

You can change the status quo.

Personalizing dialysis with Tablo:
A new clinical paradigm is possible

Nephrologists

The current landscape

Today, Renal Replacement Therapy is prescribed for long periods of time, then patients “drop” to IHD due to a lack of options. 

Outset time chart

Adapting to patients’ needs

With Tablo, there is the opportunity to deliver treatment up to 24 hours and incrementally decrease treatment time, get patients mobile on “off tx time” and potentially improve outcomes by slowly bringing them to IHD.

Clinical
versatility
Tablo is a first-of-its-kind system for standardized care in dialysis, covering 95% of hospital dialysis treatments, with durations up to 24 hours.
Sophisticated
simplicity
Designed to be easy to learn and use, Tablo empowers professionals – and patients – to confidently set up and manage dialysis treatments.
Intelligent
technology
Two-way cloud communication supports efficient documentation, adding value with an option for EMR integration.

Qd of 300 mL/min achieves similar clearance as ≥500 mL/min

Tailor therapy to your patients’ clinical needs, not to the limitations of your dialysis machines.

Nephrologists

Explore training options, resources, services and specialized programs that support a successful transition to Tablo.

Tablo can lead to an easier transition to home dialysis*

Nephrologists

Training

Average training time on Tablo is only 2 weeks, compared to 4-6 weeks with the other device.

Clearance Goals

All patients successfully achieved clearance goals (Kt/V of ≥ 2.0) in fewer avg. weekly treatments.

Nephrologists
Nephrologists

Adherence and Success

Using Tablo leads to high rates of treatment adherence and treatment success at home.†

*Compared to NxStage 
†D. E. Henner: Transition of a Home Hemodialysis Program to the Tablo System. ADC 2021.

Nephrologists

3 Nephrologists Explain 3 Keys to Growing Home Dialysis

 

Education, telehealth, and incentives are key elements needed to empower more kidney disease patients to dialyze at home, say three seasoned nephrologists.

DISCLAIMERS:

*The Tablo® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device. The Tablo Hemodialysis System is also indicated for use in the home. Treatment types available include Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/ SLEDD), Prolonged Intermittent Renal Replacement Therapy (PIRRT), and Isolated Ultrafiltration.

This device is not indicated for continuous renal replacement therapy (CRRT) and is cleared for use for up to 24 hours. The dialysate generated by this device is not sterile and should not be used for intravenous (IV) infusion.
2214-v1
1354-v6 (v6.0)

DISCLAIMERS:

*The Tablo® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device. The Tablo Hemodialysis System is also indicated for use in the home. Treatment types available include Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/ SLEDD), Prolonged Intermittent Renal Replacement Therapy (PIRRT), and Isolated Ultrafiltration.

This device is not indicated for continuous renal replacement therapy (CRRT) and is cleared for use for up to 24 hours. The dialysate generated by this device is not sterile and should not be used for intravenous (IV) infusion.
2214-v1
Stay connected
© 2024 Outset Medical, Inc. All rights reserved. Outset, Tablo, TabloCart, MyTablo, TabloHub, and Better Begins Now are trademarks of our company.